Prolonging Treatment with Lomerizine May Increase Chemosensitivity of K562/A02 to Adriamycin

KANG Kai,LI Yun-man,FANG Wei-rong,JIANG Yi,ZHANG Lu-yong
DOI: https://doi.org/10.3969/j.issn.1001-5094.2006.09.006
2006-01-01
Abstract:Objective: This experiment was to study the reversal effect of lomerizine on multidrug resistance(MDR)in K562/A02 at high concentration and after long-time treatment,as well as to study its mechanism.Methods: After preincubating human leukemic cell line K562 and its multidrug resistant counterpart K562/A02 cells with lomerizine for 24, 48 or 72 hours, ADM was added. Cytotoxicity was evaluated by MTT assay, intracellular Rh123 retention was measured by flow cytometry, and cellular [Ca~ 2+ ]_ i was measured by fluo-3/AM. Results: K562/A02 cells reduced Rh123 retention compared to their parental K562 cells. Lomerizine could diminish the IC_ 50 value of ADM to K562/A02, increase Rh123 retention and cellular [Ca~ 2+ ]_ i in K562/A02 cells after preincubation. Conclusion: Lomerizine could reverse the MDR in K562/A02 cells by inhibiting the functional activity of P-gp and increasing the chemosensibility of K562/A02 to ADM at high concentration and after long-time treatment. The reversal mechanism may be through increasing cellular [Ca~ 2+ ]_ i .
What problem does this paper attempt to address?